THERAPEUTIC OR PROPHYLACTIC AGENT FOR NOCTURNAL POLYURIA

摘要

There is provided a pharmaceutical composition which includes, as an active ingredient, a combination drug formulation of potassium citrate and sodium citrate hydrate or a sodium bicarbonate formulation. The prevention or treatment of nocturnal polyuria is achieved by administering the pharmaceutical composition.